Benzinga | Oct 1, 2020 05:34AM EDT

Dr. Reddy's Launches Cinacalcet Tablets in the U.S. Market

Dr. Reddy's Laboratories Ltd. (NYSE:RDY)announced the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

The Sensipar brand and generic market had U.S. sales of approximately $312 million MAT for the most recent twelve months ending in July 2020 according to IQVIA Health*.

Dr. Reddy's Cinacalcet Tablets are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30.